Skip to Main Content

A Study of LAM-002A for the Prevention of Progression of COVID-19

Conditions

COVID-19 Inpatient | COVID-19 Outpatient

Phase COVID-II

What is the purpose of this trial?

This is a clinical trial to evaluate the efficacy of LAM-002A compared to placebo treatment in adults with a confirmed SARS-CoV-2 infection who are receiving standards supportive care in an outpatient setting.

  • Trial with
    Yale University School of Medicine
  • Start Date
    07/19/2020
  • End Date
    12/30/2020
Trial Image

For more information about this study, contact:

Lindsey Fraczkiewicz, RN

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/22/2020
  • Study HIC
    #2000028522